Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
19.38
+0.03 (0.16%)
At close: Jun 5, 2026, 4:00 PM EDT
19.41
+0.03 (0.15%)
After-hours: Jun 5, 2026, 7:56 PM EDT
Baxter International Revenue
Baxter International had revenue of $2.70B in the quarter ending March 31, 2026, with 2.90% growth. This brings the company's revenue in the last twelve months to $11.32B, up 5.10% year-over-year. In the year 2025, Baxter International had annual revenue of $11.24B with 5.72% growth.
Revenue (ttm)
$11.32B
Revenue Growth
+5.10%
P/S Ratio
0.88
Revenue / Employee
$301,867
Employees
37,500
Market Cap
10.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.24B | 608.00M | 5.72% |
| Dec 31, 2024 | 10.64B | 276.00M | 2.66% |
| Dec 31, 2023 | 10.36B | 303.00M | 3.01% |
| Dec 31, 2022 | 10.06B | -2.09B | -17.20% |
| Dec 31, 2021 | 12.15B | 473.00M | 4.05% |
| Dec 31, 2020 | 11.67B | 311.00M | 2.74% |
| Dec 31, 2019 | 11.36B | 263.00M | 2.37% |
| Dec 31, 2018 | 11.10B | 515.00M | 4.87% |
| Dec 31, 2017 | 10.58B | 421.00M | 4.14% |
| Dec 31, 2016 | 10.16B | 195.00M | 1.96% |
| Dec 31, 2015 | 9.97B | -751.00M | -7.01% |
| Dec 31, 2014 | 10.72B | 1.31B | 13.87% |
| Dec 31, 2013 | 9.41B | -4.52B | -32.46% |
| Dec 31, 2012 | 13.94B | 43.00M | 0.31% |
| Dec 31, 2011 | 13.89B | 1.05B | 8.18% |
| Dec 31, 2010 | 12.84B | 281.00M | 2.24% |
| Dec 31, 2009 | 12.56B | 214.00M | 1.73% |
| Dec 31, 2008 | 12.35B | 1.09B | 9.63% |
| Dec 31, 2007 | 11.26B | 885.00M | 8.53% |
| Dec 31, 2006 | 10.38B | 529.00M | 5.37% |
| Dec 31, 2005 | 9.85B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Solventum | 8.26B |
| Avantor | 6.55B |
| Bausch + Lomb | 5.21B |
| The Cooper Companies | 4.23B |
| Align Technology | 4.10B |
| AptarGroup | 3.87B |
| West Pharmaceutical Services | 3.22B |
| MiniMed Group | 3.10B |
BAX News
- 4 days ago - Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong. - Market Watch
- 10 days ago - Baxter downgraded to Sell from Neutral at Citi - TheFly
- 25 days ago - Baxter International Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Baxter International Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Baxter price target raised to $27 from $25 at Barclays - TheFly
- 5 weeks ago - Baxter price target lowered to $17 from $19 at Goldman Sachs - TheFly
- 5 weeks ago - Baxter International Earnings Call Transcript: Q1 2026 - Transcripts
- 5 weeks ago - Baxter International Slides: Q1 2026 - Filings